Contributors |
|
xi | |
Foreword |
|
xxix | |
Foreword to the First Edition |
|
xxxi | |
Preface |
|
xxxiii | |
|
Section 1 Foundation Issues |
|
|
1 | (20) |
|
|
|
|
|
|
e1 Health Literacy and Medication Use |
|
|
1 | (2) |
|
|
|
|
|
|
3 | (2) |
|
|
|
|
Jessica M. Shenberger-Trujillo |
|
|
e3 Medication Safety Principles and Practices |
|
|
5 | (2) |
|
|
e4 Clinical Pharmacokinetics and Pharmacodynamics |
|
|
7 | (2) |
|
|
|
9 | (2) |
|
|
|
|
11 | (2) |
|
|
|
|
13 | (2) |
|
|
|
|
|
|
|
|
15 | (2) |
|
|
|
|
17 | (2) |
|
|
e10 Clinical Management of Potential Bioterrorism-related Conditions |
|
|
19 | (2) |
|
|
|
|
|
Section 2 Cardiovascular Disorders |
|
|
21 | (322) |
|
|
|
|
|
e11 Cardiovascular Testing |
|
|
21 | (2) |
|
|
|
23 | (22) |
|
|
|
45 | (34) |
|
|
|
|
79 | (38) |
|
|
|
|
15 Acute Decompensated Heart Failure |
|
|
117 | (18) |
|
|
|
16 Stable Ischemic Heart Disease |
|
|
135 | (30) |
|
|
17 Acute Coronary Syndromes |
|
|
165 | (28) |
|
|
|
|
|
|
193 | (38) |
|
|
|
19 Venous Thromboembolism |
|
|
231 | (30) |
|
|
|
|
|
261 | (10) |
|
|
|
|
271 | (28) |
|
|
e22 Peripheral Arterial Disease |
|
|
299 | (2) |
|
|
|
23 Use of Vasopressors and Inotropes in the Pharmacotherapy of Shock |
|
|
301 | (22) |
|
|
|
|
|
323 | (18) |
|
|
e25 Introduction to Pulmonary Function Testing |
|
|
341 | (2) |
|
|
|
|
|
Section 3 Respiratory Disorders |
|
|
343 | (90) |
|
|
|
|
|
343 | (32) |
|
|
|
27 Chronic Obstructive Pulmonary Disease |
|
|
375 | (26) |
|
|
|
28 Pulmonary Arterial Hypertension |
|
|
401 | (16) |
|
|
|
|
|
417 | (14) |
|
|
|
e30 Drug-Induced Pulmonary Diseases |
|
|
431 | (2) |
|
|
|
Section 4 Gastrointestinal Disorders |
|
|
433 | (154) |
|
|
|
|
e31 Evaluation of the Gastrointestinal Tract |
|
|
433 | (2) |
|
|
|
32 Gastroesophageal Reflux Disease |
|
|
435 | (18) |
|
|
|
|
33 Peptic Ulcer Disease and Related Disorders |
|
|
453 | (24) |
|
|
|
34 Inflammatory Bowel Disease |
|
|
477 | (20) |
|
|
|
497 | (14) |
|
Leigh Anne Hylton Gravatt |
|
|
|
|
36 Diarrhea, Constipation, and Irritable Bowel Syndrome |
|
|
511 | (16) |
|
|
|
37 Portal Hypertension and Cirrhosis |
|
|
527 | (16) |
|
|
|
e38 Drug-Induced Liver Disease |
|
|
543 | (2) |
|
|
|
|
545 | (16) |
|
|
|
|
561 | (18) |
|
|
|
579 | (8) |
|
|
|
Section 5 Renal Disorders |
|
|
587 | (208) |
|
|
|
|
|
e42 Evaluation of Kidney Function |
|
|
587 | (2) |
|
|
|
589 | (20) |
|
|
|
44 Chronic Kidney Disease |
|
|
609 | (30) |
|
|
|
45 Hemodialysis and Peritoneal Dialysis |
|
|
639 | (18) |
|
|
|
|
46 Drug-Induced Kidney Disease |
|
|
657 | (18) |
|
|
|
675 | (24) |
|
|
48 Drug Therapy Individualization for Patients with Chronic Kidney Disease |
|
|
699 | (20) |
|
|
|
49 Disorders of Sodium and Water Homeostasis |
|
|
719 | (22) |
|
|
|
50 Disorders of Calcium and Phosphorus Homeostasis |
|
|
741 | (18) |
|
|
51 Disorders of Potassium and Magnesium Homeostasis |
|
|
759 | (16) |
|
|
|
|
775 | (20) |
|
|
|
Section 6 Neurologic Disorders |
|
|
795 | (148) |
|
|
|
|
|
e53 Evaluation of Neurologic Illness |
|
|
795 | (2) |
|
|
|
|
|
797 | (18) |
|
|
|
|
|
|
815 | (22) |
|
|
|
|
|
837 | (30) |
|
|
|
|
|
|
867 | (14) |
|
|
|
58 Acute Management of the Brain Injury Patient |
|
|
881 | (14) |
|
|
|
|
895 | (14) |
|
|
|
|
909 | (18) |
|
|
|
|
|
927 | (16) |
|
|
|
Section 7 Psychiatric Disorders |
|
|
943 | (196) |
|
|
|
|
|
e62 Assessment of Psychiatric Disorders |
|
|
943 | (2) |
|
|
|
|
63 Attention Deficit/Hyperactivity Disorder |
|
|
945 | (14) |
|
|
|
|
959 | (14) |
|
|
|
65 Substance-Related Disorders I: Overview and Depressants, Stimulants, and Hallucinogens |
|
|
973 | (20) |
|
|
|
66 Substance-Related Disorders II: Alcohol, Nicotine, and Caffeine |
|
|
993 | (18) |
|
|
|
|
1011 | (30) |
|
|
|
|
68 Major Depressive Disorder |
|
|
1041 | (22) |
|
|
|
|
|
1063 | (16) |
|
|
|
70 Anxiety Disorders: Generalized Anxiety, Panic, and Social Anxiety Disorders |
|
|
1079 | (20) |
|
|
|
71 Posttraumatic Stress Disorder and Obsessive-Compulsive Disorder |
|
|
1099 | (12) |
|
|
|
|
|
1111 | (12) |
|
|
|
73 Disorders Associated with Intellectual Disabilities |
|
|
1123 | (16) |
|
|
|
|
Section 8 Endocrinologic Disorders |
|
|
1139 | (90) |
|
|
|
|
|
|
1139 | (44) |
|
|
|
|
|
1183 | (24) |
|
|
|
76 Adrenal Gland Disorders |
|
|
1207 | (20) |
|
|
|
|
e77 Pituitary Gland Disorders |
|
|
1227 | (2) |
|
|
|
|
Section 9 Gynecologic and Obstetric Disorders |
|
|
1229 | (80) |
|
|
|
|
|
78 Pregnancy and Lactation: Therapeutic Considerations |
|
|
1229 | (18) |
|
|
|
1247 | (16) |
|
|
|
80 Menstruation-Related Disorders |
|
|
1263 | (16) |
|
|
|
|
1279 | (8) |
|
|
|
82 Hormone Therapy in Women |
|
|
1287 | (22) |
|
|
|
|
|
Section 10 Urologic Disorders |
|
|
1309 | (64) |
|
|
|
|
|
1309 | (26) |
|
|
|
84 Benign Prostatic Hyperplasia |
|
|
1335 | (18) |
|
|
|
|
1353 | (20) |
|
|
|
|
Section 11 Immunologic Disorders |
|
|
1373 | (46) |
|
|
|
|
|
e86 Function and Evaluation of the Immune System |
|
|
1373 | (2) |
|
|
|
|
87 Systemic Lupus Erythematosus |
|
|
1375 | (18) |
|
|
|
1393 | (2) |
|
|
89 Solid-Organ Transplantation |
|
|
1395 | (24) |
|
|
|
Section 12 Rheumatologic Disorders |
|
|
1419 | (86) |
|
|
|
|
|
1419 | (20) |
|
|
|
|
1439 | (18) |
|
|
|
92 Osteoporosis and Osteomalacia |
|
|
1457 | (28) |
|
|
|
93 Gout and Hyperuricemia |
|
|
1485 | (20) |
|
|
|
Section 13 Ophthalmic and Otolaryngological Disorders |
|
|
1505 | (30) |
|
|
|
|
|
1505 | (16) |
|
|
|
|
|
|
1521 | (14) |
|
|
Section 14 Dermatologic Disorders |
|
|
1535 | (58) |
|
|
|
|
|
1535 | (26) |
|
|
|
1561 | (18) |
|
|
|
|
1579 | (12) |
|
|
|
e99 Dermatologic Drug Reactions and Common Skin Conditions |
|
|
1591 | (2) |
|
|
|
Section 15 Hematologic Disorders |
|
|
1593 | (56) |
|
|
|
|
|
1593 | (18) |
|
|
101 Coagulation Disorders |
|
|
1611 | (18) |
|
|
|
|
|
1629 | (18) |
|
|
|
e103 Drug-Induced Hematologic Disorders |
|
|
1647 | (2) |
|
|
|
Section 16 Infectious Diseases |
|
|
1649 | (380) |
|
|
|
|
e104 Laboratory Tests to Direct Antimicrobial Pharmacotherapy |
|
|
1649 | (2) |
|
|
|
|
105 Antimicrobial Regimen Selection |
|
|
1651 | (14) |
|
|
|
106 Central Nervous System Infections |
|
|
1665 | (20) |
|
|
|
|
|
107 Lower Respiratory Tract Infections |
|
|
1685 | (24) |
|
|
|
|
108 Upper Respiratory Tract Infections |
|
|
1709 | (12) |
|
|
|
|
1721 | (12) |
|
|
110 Skin and Soft-Tissue Infections |
|
|
1733 | (28) |
|
|
111 Infective Endocarditis |
|
|
1761 | (18) |
|
|
|
|
|
1779 | (20) |
|
|
|
|
113 Gastrointestinal Infections and Enterotoxigenic Poisonings |
|
|
1799 | (14) |
|
|
|
|
114 Intra-Abdominal Infections |
|
|
1813 | (14) |
|
|
|
|
|
1827 | (2) |
|
|
|
116 Urinary Tract Infections and Prostatitis |
|
|
1829 | (16) |
|
|
|
117 Sexually Transmitted Diseases |
|
|
1845 | (20) |
|
|
|
|
118 Bone and Joint Infections |
|
|
1865 | (12) |
|
|
|
|
119 Sepsis and Septic Shock |
|
|
1877 | (14) |
|
|
120 Superficial Fungal Infections |
|
|
1891 | (20) |
|
|
|
121 Invasive Fungal Infections |
|
|
1911 | (32) |
|
|
122 Infections in Immunocompromised Patients |
|
|
1943 | (30) |
|
|
|
123 Antimicrobial Prophylaxis in Surgery |
|
|
1973 | (16) |
|
|
|
1989 | (2) |
|
|
|
125 Vaccines and Immunoglobulins |
|
|
1991 | (16) |
|
|
126 Human Immunodeficiency Virus Infection |
|
|
2007 | (22) |
|
|
|
|
Section 17 Oncologic Disorders |
|
|
2029 | (294) |
|
|
|
|
127 Cancer Treatment and Chemotherapy |
|
|
2029 | (48) |
|
|
|
|
2077 | (40) |
|
|
|
|
|
2117 | (16) |
|
|
|
|
2133 | (32) |
|
|
|
|
|
2165 | (16) |
|
|
|
|
2181 | (28) |
|
|
|
|
2209 | (16) |
|
|
|
|
2225 | (22) |
|
|
|
|
2247 | (18) |
|
|
|
|
2265 | (16) |
|
|
|
e137 Myelodysplastic Syndromes |
|
|
2281 | (2) |
|
|
|
e138 Renal Cell Carcinoma |
|
|
2283 | (2) |
|
|
|
|
2285 | (20) |
|
|
|
140 Hematopoietic Stem Cell Transplantation |
|
|
2305 | (18) |
|
|
|
Section 18 Nutritional Disorders |
|
|
2323 | (80) |
|
|
|
|
141 Assessment of Nutrition Status and Nutrition Requirements |
|
|
2323 | (22) |
|
|
|
|
2345 | (22) |
|
|
|
|
2367 | (18) |
|
|
|
|
2385 | (18) |
|
|
|
|
Index |
|
2403 | |